HIGHLIGHTS
- who: Ying Li from the Anhui Normal University, China have published the article: TCR-like antibodies targeting autoantigen-mhc complexes: a mini-review, in the Journal: (JOURNAL)
- what: As other reviews have summarized TCRL mAb generation , the authors focus on the available approaches relevant to TCRL mAbs specific for p/MHC-II.
- future: The authors review current approaches and future directions for generating and using TCRL (also known as TCR mimic) Abs as research tools and potential therapeutics for autoimmune diseases.
SUMMARY
To date, over 80 autoimmune diseases have . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.